Dr Mike Molinari: Ledger

Stories naming Dr Mike Molinari. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Managing Director	IP Group Australia	SmartCompany, IP Group Australia team page

Series A $29m

RAGE Biotech raises $29 million for new lung disease treatment

Melbourne biotech RAGE Biotech has raised a $29 million Series A, with IP Group Australia and Hostplus leading, to fund human trials of its lung disease therapy; new executives were appointed.

SmartCompany Thu 13 Nov 2025 RAGE Biotech Monash University Hostplus IP Group Australia Monash Ventures Dr Chris Wraight Dr Edwin Tucker Dr Mike Molinari Dr Siro Perez

Also Startup Daily

Dr Mike Molinari

Roles

Coverage

RAGE Biotech raises $29 million for new lung disease treatment